Edgar Gonzalez
General Practice · Miami, FLNPI 1801132121
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,044 of the $5,150 with a category attached, or 78.5%. 9 manufacturers reported payments, led by Chiesi USA, Inc. at 52.7% of the total. Reporting peaked in 2023 at $4,884 and has fallen 99.6% since, to $18 in 2025. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $160.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Chiesi USA, Inc.$3K
- Alnylam Pharmaceuticals Inc.$1K
- Genentech USA, Inc.$859
- Boehringer Ingelheim$150
- AbbVie$105
- Novo Nordisk$52
- plus $105 from 3 others
Across 874 payments — averaging $3446.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$1.4M
- AbbVie$443K
- Bayer$404K
- Teva Pharmaceuticals USA, Inc.$279K
- Genentech, Inc.$147K
- Akebia Therapeutics Inc$113K
- plus $234K from 7 others
What the payments were for
- Travel & lodging$4,04479%
- Food & beverage$1,10621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Chiesi USA, Inc. | 3 | $2,715 |
| Alnylam Pharmaceuticals Inc. | 9 | $1,162 |
| Genentech USA, Inc. | 3 | $859 |
| Boehringer Ingelheim | 2 | $150 |
| AbbVie(2 entities) | 6 | $105 |
| Novo Nordisk | 3 | $52 |
| Johnson & Johnson | 3 | $52 |
| AstraZeneca | 2 | $34 |
| Gilead | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$129
How this compares
$5,150 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $76,538 |
| EliquisApixaban | 32 | $28,985 |
| BreynaBudesonide/Formoterol Fumarate | 14 | $3,228 |
| Tadalafil | 38 | $2,328 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,457 |
| Atorvastatin Calcium | 192 | $1,233 |
| Omeprazole | 128 | $1,221 |
| Levothyroxine Sodium | 93 | $951 |
| Enalapril Maleate | 74 | $940 |
| Losartan Potassium | 84 | $821 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $781 |
| Diclofenac Sodium | 35 | $706 |
| Pentoxifylline | 41 | $700 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 193 | $631 |
| Donepezil Hcl | 87 | $587 |
Paid to pharmacies, not to this prescriber.
Other general practice in Miami
- Idalia AcostaMiami$99K
- Eddie GomezMiami$59K
- Aladino ValienteMiami$24K
- Viviana WaichMiami$20K
- Libia RiosMiami$15K
- Jose CardonaMiami$15K
- Rosa HuguetMiami$15K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.